WILMINGTON, Del.--(BUSINESS WIRE)--Aug 28, 2018--Incyte Corporation (Nasdaq:INCY) announced today that it will present at the Morgan Stanley 16 th Annual Global Healthcare Conference on Thursday, September 13, 2018 at 10:00 am EDT in New York.

The presentation and Q&A session will be webcast live and can be accessed at www.incyte.com in the Investors section under “Events and Presentations.” Investors interested in listening to the live webcast should log on before the start time in order to download any software required.

About Incyte

Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit the Company's web site at www.incyte.com.

Follow @Incyte on Twitter at https://twitter.com/Incyte.

View source version on businesswire.com:https://www.businesswire.com/news/home/20180828005011/en/

CONTACT: Incyte Corporation

Media

Catalina Loveman, +1 302-498-6171

cloveman@incyte.com

or

Investors

Michael Booth, DPhil, +1 302-498-5914

mbooth@incyte.com

KEYWORD: UNITED STATES NORTH AMERICA DELAWARE NEW YORK

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL

SOURCE: Incyte Corporation

Copyright Business Wire 2018.

PUB: 08/28/2018 08:00 AM/DISC: 08/28/2018 08:01 AM

http://www.businesswire.com/news/home/20180828005011/en